Alvotech shares rise as FDA completes Reykjavik facility inspection
Source: SeekingAlpha
2026-05-11 07:10:05 ET
More on Alvotech
- Alvotech (ALVO) Q1 2026 Earnings Call Transcript
- Alvotech 2026 Q1 - Results - Earnings Call Presentation
- Alvotech: Improving Fundamentals Signal A Potential Bottom For This Biosimilar Player
- Quant snapshot: Lumentum, Fastly among top-rated names as SUI Group, Service Properties lag
- Alvotech outlines 2026 revenue target of $650M-$700M while expanding global biosimilar launches
Read the full article on Seeking Alpha
For further details see:
Alvotech shares rise as FDA completes Reykjavik facility inspection
Alvotech
NASDAQ: ALVO
ALVO Trading
-0.87% G/L:
$3.415 Last:
198,469 Volume:
$3.46 Open:
ALVO Latest News
May 11, 2026 04:30:00 am
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
